During the past decade, Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 24 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 15 clinical trials were completed. i.e. 107.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Pfizer" with 8 trials sponsored, "BeiGene" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" are "Multiple Myeloma" (6 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Gastric Cancer" (4 trials), "Renal Cell Carcinoma" (4 trials) and "Small Lymphocytic Lymphoma" (3 trials). Many other conditions were trialed in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" in a lesser frequency.

Most popular intervention types in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" are "Drug" (50 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Rituximab" (7 trials), "Dexamethasone" (5 trials), "Atezolizumab" (4 trials) and "Capecitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" are 47 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza". undefined are not yet recruiting, 11 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza has several departments that took part in Clinical trials: "Szpital Specjalistyczny POO im. ks. B.Markiewicza; Dzienny Oddz Chemioter i Hematologii Onkol" - 2 trials